Project
Illumina Body Map 2
Navigation
Downloads
Results for GLIS2
Z-value: 1.26
Motif logo
Transcription factors associated with GLIS2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
GLIS2
|
ENSG00000126603.4 | GLIS family zinc finger 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GLIS2 | hg19_v2_chr16_+_4364762_4364762 | 0.29 | 1.0e-01 | Click! |
Activity profile of GLIS2 motif
Sorted Z-values of GLIS2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_50868882 | 4.50 |
ENST00000598915.1
|
NAPSA
|
napsin A aspartic peptidase |
| chr22_+_23264766 | 2.98 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr19_+_55795493 | 2.87 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
| chr11_-_1036706 | 2.41 |
ENST00000421673.2
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming |
| chr19_+_17858509 | 2.37 |
ENST00000594202.1
ENST00000252771.7 ENST00000389133.4 |
FCHO1
|
FCH domain only 1 |
| chr14_+_94640633 | 2.28 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr19_-_821931 | 2.23 |
ENST00000359894.2
ENST00000520876.3 ENST00000519502.1 |
LPPR3
|
hsa-mir-3187 |
| chr2_-_89310012 | 2.20 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr16_-_29910365 | 1.98 |
ENST00000346932.5
ENST00000350527.3 ENST00000537485.1 ENST00000568380.1 |
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
| chr19_+_45973120 | 1.96 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr16_-_29910853 | 1.88 |
ENST00000308713.5
|
SEZ6L2
|
seizure related 6 homolog (mouse)-like 2 |
| chr2_+_24272576 | 1.86 |
ENST00000380986.4
ENST00000452109.1 |
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa |
| chr19_+_55105085 | 1.85 |
ENST00000251372.3
ENST00000453777.1 |
LILRA1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 |
| chr10_-_73848531 | 1.81 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
| chr1_+_160051319 | 1.81 |
ENST00000368088.3
|
KCNJ9
|
potassium inwardly-rectifying channel, subfamily J, member 9 |
| chr2_-_27718052 | 1.78 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
| chr3_+_118892362 | 1.76 |
ENST00000497685.1
ENST00000264234.3 |
UPK1B
|
uroplakin 1B |
| chr3_+_118892411 | 1.65 |
ENST00000479520.1
ENST00000494855.1 |
UPK1B
|
uroplakin 1B |
| chr5_+_68788594 | 1.63 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
| chr9_+_135037334 | 1.62 |
ENST00000393229.3
ENST00000360670.3 ENST00000393228.4 ENST00000372179.3 |
NTNG2
|
netrin G2 |
| chr19_+_45417504 | 1.59 |
ENST00000588750.1
ENST00000588802.1 |
APOC1
|
apolipoprotein C-I |
| chr15_-_79383102 | 1.57 |
ENST00000558480.2
ENST00000419573.3 |
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1 |
| chr11_-_796197 | 1.57 |
ENST00000530360.1
ENST00000528606.1 ENST00000320230.5 |
SLC25A22
|
solute carrier family 25 (mitochondrial carrier: glutamate), member 22 |
| chr14_-_107114267 | 1.56 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr1_+_201979645 | 1.55 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chr19_+_45418067 | 1.54 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
| chr1_-_186649543 | 1.52 |
ENST00000367468.5
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
| chr19_+_45409011 | 1.48 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr1_-_156675535 | 1.48 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr20_+_30640004 | 1.47 |
ENST00000520553.1
ENST00000518730.1 ENST00000375852.2 |
HCK
|
hemopoietic cell kinase |
| chr2_+_24272543 | 1.46 |
ENST00000380991.4
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa |
| chr20_+_44637526 | 1.45 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
| chr1_-_156675564 | 1.44 |
ENST00000368220.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr19_+_11200038 | 1.43 |
ENST00000558518.1
ENST00000557933.1 ENST00000455727.2 ENST00000535915.1 ENST00000545707.1 ENST00000558013.1 |
LDLR
|
low density lipoprotein receptor |
| chr10_-_104179682 | 1.42 |
ENST00000406432.1
|
PSD
|
pleckstrin and Sec7 domain containing |
| chr11_+_66045634 | 1.40 |
ENST00000528852.1
ENST00000311445.6 |
CNIH2
|
cornichon family AMPA receptor auxiliary protein 2 |
| chr16_+_811073 | 1.40 |
ENST00000382862.3
ENST00000563651.1 |
MSLN
|
mesothelin |
| chr19_+_30017406 | 1.39 |
ENST00000335523.7
|
VSTM2B
|
V-set and transmembrane domain containing 2B |
| chr19_+_45417921 | 1.39 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
| chr14_+_24540731 | 1.38 |
ENST00000558859.1
ENST00000559197.1 ENST00000560828.1 ENST00000216775.2 ENST00000560884.1 |
CPNE6
|
copine VI (neuronal) |
| chr20_+_44657845 | 1.38 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
| chr6_-_2903514 | 1.38 |
ENST00000380698.4
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
| chr1_+_43637996 | 1.35 |
ENST00000528956.1
ENST00000529956.1 |
WDR65
|
WD repeat domain 65 |
| chr14_+_103566481 | 1.35 |
ENST00000380069.3
|
EXOC3L4
|
exocyst complex component 3-like 4 |
| chr2_+_89952792 | 1.35 |
ENST00000390265.2
|
IGKV1D-33
|
immunoglobulin kappa variable 1D-33 |
| chr7_+_2671663 | 1.33 |
ENST00000407643.1
|
TTYH3
|
tweety family member 3 |
| chr2_+_208527094 | 1.31 |
ENST00000429730.1
|
AC079767.4
|
AC079767.4 |
| chr19_+_45417812 | 1.29 |
ENST00000592535.1
|
APOC1
|
apolipoprotein C-I |
| chr8_+_27183033 | 1.29 |
ENST00000420218.2
|
PTK2B
|
protein tyrosine kinase 2 beta |
| chrX_+_152783131 | 1.28 |
ENST00000349466.2
ENST00000370186.1 |
ATP2B3
|
ATPase, Ca++ transporting, plasma membrane 3 |
| chr16_+_2198604 | 1.28 |
ENST00000210187.6
|
RAB26
|
RAB26, member RAS oncogene family |
| chr1_+_201979743 | 1.26 |
ENST00000446188.1
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chrX_+_118370211 | 1.26 |
ENST00000217971.7
|
PGRMC1
|
progesterone receptor membrane component 1 |
| chr1_-_156675368 | 1.24 |
ENST00000368222.3
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr5_-_176836577 | 1.24 |
ENST00000253496.3
|
F12
|
coagulation factor XII (Hageman factor) |
| chr19_+_15619299 | 1.22 |
ENST00000269703.3
|
CYP4F22
|
cytochrome P450, family 4, subfamily F, polypeptide 22 |
| chr14_+_101293687 | 1.21 |
ENST00000455286.1
|
MEG3
|
maternally expressed 3 (non-protein coding) |
| chr14_-_106330824 | 1.20 |
ENST00000463911.1
|
IGHJ3
|
immunoglobulin heavy joining 3 |
| chrX_+_118370288 | 1.19 |
ENST00000535419.1
|
PGRMC1
|
progesterone receptor membrane component 1 |
| chr20_+_30639991 | 1.19 |
ENST00000534862.1
ENST00000538448.1 ENST00000375862.2 |
HCK
|
hemopoietic cell kinase |
| chr19_-_16008880 | 1.19 |
ENST00000011989.7
ENST00000221700.6 |
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2 |
| chrX_+_53078273 | 1.16 |
ENST00000332582.4
|
GPR173
|
G protein-coupled receptor 173 |
| chr20_-_52687059 | 1.13 |
ENST00000371435.2
ENST00000395961.3 |
BCAS1
|
breast carcinoma amplified sequence 1 |
| chr14_-_107211459 | 1.13 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
| chr12_-_122107549 | 1.12 |
ENST00000355329.3
|
MORN3
|
MORN repeat containing 3 |
| chr14_+_24540761 | 1.12 |
ENST00000559207.1
|
CPNE6
|
copine VI (neuronal) |
| chr14_+_105391147 | 1.11 |
ENST00000540372.1
ENST00000392593.4 |
PLD4
|
phospholipase D family, member 4 |
| chr1_-_117753540 | 1.11 |
ENST00000328189.3
ENST00000369458.3 |
VTCN1
|
V-set domain containing T cell activation inhibitor 1 |
| chr17_-_79481666 | 1.10 |
ENST00000575659.1
|
ACTG1
|
actin, gamma 1 |
| chr2_+_149895207 | 1.10 |
ENST00000409876.1
|
LYPD6B
|
LY6/PLAUR domain containing 6B |
| chr17_-_38020392 | 1.10 |
ENST00000346872.3
ENST00000439167.2 ENST00000377945.3 ENST00000394189.2 ENST00000377944.3 ENST00000377958.2 ENST00000535189.1 ENST00000377952.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
| chr9_+_133884469 | 1.09 |
ENST00000361069.4
|
LAMC3
|
laminin, gamma 3 |
| chr19_+_782755 | 1.08 |
ENST00000606242.1
ENST00000586061.1 |
AC006273.5
|
AC006273.5 |
| chr19_-_54850417 | 1.07 |
ENST00000291759.4
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 |
| chr19_+_16830815 | 1.06 |
ENST00000549814.1
|
NWD1
|
NACHT and WD repeat domain containing 1 |
| chr4_-_5021164 | 1.05 |
ENST00000506508.1
ENST00000509419.1 ENST00000307746.4 |
CYTL1
|
cytokine-like 1 |
| chr7_+_2695726 | 1.04 |
ENST00000429448.1
|
TTYH3
|
tweety family member 3 |
| chr20_+_44657807 | 1.03 |
ENST00000372315.1
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
| chr1_+_91966656 | 1.03 |
ENST00000428239.1
ENST00000426137.1 |
CDC7
|
cell division cycle 7 |
| chr14_+_105559784 | 1.02 |
ENST00000548104.1
|
RP11-44N21.1
|
RP11-44N21.1 |
| chr19_-_54784937 | 1.02 |
ENST00000434421.1
ENST00000314446.5 ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr16_+_25703274 | 1.02 |
ENST00000331351.5
|
HS3ST4
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
| chr11_+_1244288 | 1.00 |
ENST00000529681.1
ENST00000447027.1 |
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming |
| chr22_+_22681656 | 1.00 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr22_-_30661807 | 0.99 |
ENST00000403389.1
|
OSM
|
oncostatin M |
| chr5_-_1524015 | 0.99 |
ENST00000283415.3
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1 |
| chr8_-_103136481 | 0.99 |
ENST00000524209.1
ENST00000517822.1 ENST00000523923.1 ENST00000521599.1 ENST00000521964.1 ENST00000311028.3 ENST00000518166.1 |
NCALD
|
neurocalcin delta |
| chr3_+_151531859 | 0.98 |
ENST00000488869.1
|
AADAC
|
arylacetamide deacetylase |
| chr1_+_91966384 | 0.98 |
ENST00000430031.2
ENST00000234626.6 |
CDC7
|
cell division cycle 7 |
| chr19_+_17858547 | 0.98 |
ENST00000600676.1
ENST00000600209.1 ENST00000596309.1 ENST00000598539.1 ENST00000597474.1 ENST00000593385.1 ENST00000598067.1 ENST00000593833.1 |
FCHO1
|
FCH domain only 1 |
| chr16_+_2521500 | 0.96 |
ENST00000293973.1
|
NTN3
|
netrin 3 |
| chr17_-_38020379 | 0.96 |
ENST00000351680.3
ENST00000346243.3 ENST00000350532.3 ENST00000467757.1 ENST00000439016.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
| chr14_-_54955721 | 0.96 |
ENST00000554908.1
|
GMFB
|
glia maturation factor, beta |
| chr6_+_43044003 | 0.93 |
ENST00000230419.4
ENST00000476760.1 ENST00000471863.1 ENST00000349241.2 ENST00000352931.2 ENST00000345201.2 |
PTK7
|
protein tyrosine kinase 7 |
| chr15_+_74610894 | 0.91 |
ENST00000558821.1
ENST00000268082.4 |
CCDC33
|
coiled-coil domain containing 33 |
| chr3_+_151531810 | 0.91 |
ENST00000232892.7
|
AADAC
|
arylacetamide deacetylase |
| chr19_+_16830774 | 0.89 |
ENST00000524140.2
|
NWD1
|
NACHT and WD repeat domain containing 1 |
| chr7_-_158380371 | 0.89 |
ENST00000389418.4
ENST00000389416.4 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
| chr20_-_52687030 | 0.88 |
ENST00000411563.1
|
BCAS1
|
breast carcinoma amplified sequence 1 |
| chr13_-_95248511 | 0.88 |
ENST00000261296.5
|
TGDS
|
TDP-glucose 4,6-dehydratase |
| chr13_-_46425865 | 0.87 |
ENST00000400405.2
|
SIAH3
|
siah E3 ubiquitin protein ligase family member 3 |
| chr13_-_20767037 | 0.87 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
| chr17_+_7461580 | 0.87 |
ENST00000483039.1
ENST00000396542.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
| chr8_-_143833918 | 0.87 |
ENST00000359228.3
|
LYPD2
|
LY6/PLAUR domain containing 2 |
| chr1_-_226187013 | 0.87 |
ENST00000272091.7
|
SDE2
|
SDE2 telomere maintenance homolog (S. pombe) |
| chr19_+_45251804 | 0.87 |
ENST00000164227.5
|
BCL3
|
B-cell CLL/lymphoma 3 |
| chr8_-_95565673 | 0.87 |
ENST00000437199.1
ENST00000297591.5 ENST00000421249.2 |
KIAA1429
|
KIAA1429 |
| chr7_-_73133959 | 0.85 |
ENST00000395155.3
ENST00000395154.3 ENST00000222812.3 ENST00000395156.3 |
STX1A
|
syntaxin 1A (brain) |
| chr22_+_22786288 | 0.85 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr19_+_4304685 | 0.83 |
ENST00000601006.1
|
FSD1
|
fibronectin type III and SPRY domain containing 1 |
| chr4_-_122686261 | 0.83 |
ENST00000337677.5
|
TMEM155
|
transmembrane protein 155 |
| chrX_-_48823165 | 0.82 |
ENST00000419374.1
|
KCND1
|
potassium voltage-gated channel, Shal-related subfamily, member 1 |
| chr22_+_45072925 | 0.81 |
ENST00000006251.7
|
PRR5
|
proline rich 5 (renal) |
| chr17_-_8198636 | 0.81 |
ENST00000577745.1
ENST00000579192.1 ENST00000396278.1 |
SLC25A35
|
solute carrier family 25, member 35 |
| chr1_+_15671580 | 0.81 |
ENST00000529606.1
ENST00000314740.8 |
FHAD1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
| chr8_+_27182862 | 0.80 |
ENST00000521164.1
ENST00000346049.5 |
PTK2B
|
protein tyrosine kinase 2 beta |
| chr11_+_121447469 | 0.80 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr19_+_7733929 | 0.80 |
ENST00000221515.2
|
RETN
|
resistin |
| chr11_-_795400 | 0.79 |
ENST00000526152.1
ENST00000456706.2 ENST00000528936.1 |
SLC25A22
|
solute carrier family 25 (mitochondrial carrier: glutamate), member 22 |
| chr2_-_230933623 | 0.78 |
ENST00000457406.1
|
SLC16A14
|
solute carrier family 16, member 14 |
| chrX_+_102631844 | 0.78 |
ENST00000372634.1
ENST00000299872.7 |
NGFRAP1
|
nerve growth factor receptor (TNFRSF16) associated protein 1 |
| chr1_-_36947120 | 0.78 |
ENST00000361632.4
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
| chr19_-_3479086 | 0.77 |
ENST00000587847.1
|
C19orf77
|
chromosome 19 open reading frame 77 |
| chr6_-_89827720 | 0.77 |
ENST00000452027.2
|
SRSF12
|
serine/arginine-rich splicing factor 12 |
| chr12_-_51785182 | 0.76 |
ENST00000356317.3
ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
| chr2_-_109605663 | 0.76 |
ENST00000409271.1
ENST00000258443.2 ENST00000376651.1 |
EDAR
|
ectodysplasin A receptor |
| chrX_+_51927919 | 0.76 |
ENST00000416960.1
|
MAGED4
|
melanoma antigen family D, 4 |
| chr1_-_28520447 | 0.76 |
ENST00000539896.1
|
PTAFR
|
platelet-activating factor receptor |
| chr1_+_21766641 | 0.75 |
ENST00000342104.5
|
NBPF3
|
neuroblastoma breakpoint family, member 3 |
| chr1_-_16939976 | 0.75 |
ENST00000430580.2
|
NBPF1
|
neuroblastoma breakpoint family, member 1 |
| chr6_-_133119668 | 0.75 |
ENST00000275227.4
ENST00000538764.1 |
SLC18B1
|
solute carrier family 18, subfamily B, member 1 |
| chr6_+_33048222 | 0.74 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
| chrX_+_152240819 | 0.74 |
ENST00000421798.3
ENST00000535416.1 |
PNMA6C
PNMA6A
|
paraneoplastic Ma antigen family member 6C paraneoplastic Ma antigen family member 6A |
| chr1_-_24127256 | 0.74 |
ENST00000418277.1
|
GALE
|
UDP-galactose-4-epimerase |
| chr12_+_57998400 | 0.72 |
ENST00000548804.1
ENST00000550596.1 ENST00000551835.1 ENST00000549583.1 |
DTX3
|
deltex homolog 3 (Drosophila) |
| chr1_-_153348067 | 0.72 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
| chr19_-_51071302 | 0.71 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
| chr4_-_111120132 | 0.71 |
ENST00000506625.1
|
ELOVL6
|
ELOVL fatty acid elongase 6 |
| chr5_-_131826457 | 0.71 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
| chr20_-_23402028 | 0.70 |
ENST00000398425.3
ENST00000432543.2 ENST00000377026.4 |
NAPB
|
N-ethylmaleimide-sensitive factor attachment protein, beta |
| chr7_-_158380465 | 0.70 |
ENST00000389413.3
ENST00000409483.1 |
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
| chr14_+_105391181 | 0.70 |
ENST00000557573.1
|
PLD4
|
phospholipase D family, member 4 |
| chr2_+_98703595 | 0.69 |
ENST00000435344.1
|
VWA3B
|
von Willebrand factor A domain containing 3B |
| chr16_+_84209539 | 0.69 |
ENST00000569735.1
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
| chr2_-_230933709 | 0.69 |
ENST00000436869.1
ENST00000295190.4 |
SLC16A14
|
solute carrier family 16, member 14 |
| chr4_-_48082192 | 0.69 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
| chr1_-_209824643 | 0.69 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
| chr12_+_50451462 | 0.68 |
ENST00000447966.2
|
ASIC1
|
acid-sensing (proton-gated) ion channel 1 |
| chr3_+_153839149 | 0.68 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
| chr7_+_29237354 | 0.68 |
ENST00000546235.1
|
CHN2
|
chimerin 2 |
| chr7_-_155601766 | 0.68 |
ENST00000430104.1
|
SHH
|
sonic hedgehog |
| chr17_-_36760865 | 0.68 |
ENST00000584266.1
|
SRCIN1
|
SRC kinase signaling inhibitor 1 |
| chr19_+_45973360 | 0.67 |
ENST00000589593.1
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr1_-_228604328 | 0.67 |
ENST00000355586.4
ENST00000366698.2 ENST00000520264.1 ENST00000479800.1 ENST00000295033.3 |
TRIM17
|
tripartite motif containing 17 |
| chr7_-_752074 | 0.67 |
ENST00000360274.4
|
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
| chr7_+_133812052 | 0.67 |
ENST00000285928.2
|
LRGUK
|
leucine-rich repeats and guanylate kinase domain containing |
| chr19_-_17799008 | 0.66 |
ENST00000519716.2
|
UNC13A
|
unc-13 homolog A (C. elegans) |
| chr20_+_35974532 | 0.66 |
ENST00000373578.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
| chr22_+_45072958 | 0.66 |
ENST00000403581.1
|
PRR5
|
proline rich 5 (renal) |
| chr12_+_57998595 | 0.66 |
ENST00000337737.3
ENST00000548198.1 ENST00000551632.1 |
DTX3
|
deltex homolog 3 (Drosophila) |
| chr3_-_48470838 | 0.65 |
ENST00000358459.4
ENST00000358536.4 |
PLXNB1
|
plexin B1 |
| chr10_+_70320413 | 0.65 |
ENST00000373644.4
|
TET1
|
tet methylcytosine dioxygenase 1 |
| chr8_+_38243721 | 0.65 |
ENST00000527334.1
|
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
| chr19_-_42759300 | 0.65 |
ENST00000222329.4
|
ERF
|
Ets2 repressor factor |
| chr17_+_6939362 | 0.65 |
ENST00000308027.6
|
SLC16A13
|
solute carrier family 16, member 13 |
| chr11_+_14665263 | 0.64 |
ENST00000282096.4
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
| chr14_+_22689792 | 0.64 |
ENST00000390462.1
|
TRAV35
|
T cell receptor alpha variable 35 |
| chr8_-_29120580 | 0.64 |
ENST00000524189.1
|
KIF13B
|
kinesin family member 13B |
| chr1_+_151693984 | 0.64 |
ENST00000479191.1
|
RIIAD1
|
regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1 |
| chr19_-_39108568 | 0.64 |
ENST00000586296.1
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1 |
| chr6_-_133119649 | 0.63 |
ENST00000367918.1
|
SLC18B1
|
solute carrier family 18, subfamily B, member 1 |
| chr16_+_50308028 | 0.63 |
ENST00000566761.2
|
ADCY7
|
adenylate cyclase 7 |
| chr7_-_4998802 | 0.63 |
ENST00000406755.1
ENST00000404774.3 ENST00000401401.3 |
MMD2
|
monocyte to macrophage differentiation-associated 2 |
| chr16_+_88493879 | 0.62 |
ENST00000565624.1
ENST00000437464.1 |
ZNF469
|
zinc finger protein 469 |
| chr16_+_29150963 | 0.62 |
ENST00000563477.1
|
RP11-426C22.5
|
RP11-426C22.5 |
| chr7_-_138363824 | 0.62 |
ENST00000419765.3
|
SVOPL
|
SVOP-like |
| chr1_-_169396666 | 0.60 |
ENST00000456107.1
ENST00000367805.3 |
CCDC181
|
coiled-coil domain containing 181 |
| chr11_-_795286 | 0.60 |
ENST00000533385.1
ENST00000527723.1 |
SLC25A22
|
solute carrier family 25 (mitochondrial carrier: glutamate), member 22 |
| chr11_+_86748998 | 0.60 |
ENST00000525018.1
ENST00000355734.4 |
TMEM135
|
transmembrane protein 135 |
| chr6_+_163148161 | 0.60 |
ENST00000337019.3
ENST00000366889.2 |
PACRG
|
PARK2 co-regulated |
| chr19_+_49622646 | 0.59 |
ENST00000334186.4
|
PPFIA3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
| chr22_-_18257178 | 0.58 |
ENST00000342111.5
|
BID
|
BH3 interacting domain death agonist |
| chr6_+_29624862 | 0.58 |
ENST00000376894.4
|
MOG
|
myelin oligodendrocyte glycoprotein |
| chr12_+_50451331 | 0.58 |
ENST00000228468.4
|
ASIC1
|
acid-sensing (proton-gated) ion channel 1 |
| chr7_+_2685164 | 0.57 |
ENST00000400376.2
|
TTYH3
|
tweety family member 3 |
| chr11_-_17555421 | 0.56 |
ENST00000526181.1
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe) |
| chr9_+_135285579 | 0.56 |
ENST00000343036.2
ENST00000393216.2 |
C9orf171
|
chromosome 9 open reading frame 171 |
| chr8_+_38243967 | 0.55 |
ENST00000524874.1
ENST00000379957.4 ENST00000523983.2 |
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
| chr6_+_29624898 | 0.55 |
ENST00000396704.3
ENST00000483013.1 ENST00000490427.1 ENST00000416766.2 ENST00000376891.4 ENST00000376898.3 ENST00000396701.2 ENST00000494692.1 ENST00000431798.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
| chr11_-_74178582 | 0.55 |
ENST00000531854.1
ENST00000526855.1 ENST00000529425.1 ENST00000310128.4 ENST00000532569.1 |
KCNE3
|
potassium voltage-gated channel, Isk-related family, member 3 |
| chr17_-_45056606 | 0.55 |
ENST00000322329.3
|
RPRML
|
reprimo-like |
| chr6_+_29624758 | 0.54 |
ENST00000376917.3
ENST00000376902.3 ENST00000533330.2 ENST00000376888.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
| chr17_+_5389605 | 0.54 |
ENST00000576988.1
ENST00000576570.1 ENST00000573759.1 |
MIS12
|
MIS12 kinetochore complex component |
| chr1_-_24126892 | 0.54 |
ENST00000374497.3
ENST00000425913.1 |
GALE
|
UDP-galactose-4-epimerase |
| chr7_-_130080977 | 0.54 |
ENST00000223208.5
|
CEP41
|
centrosomal protein 41kDa |
| chrX_+_53449839 | 0.54 |
ENST00000457095.1
|
RIBC1
|
RIB43A domain with coiled-coils 1 |
| chr16_-_67185117 | 0.53 |
ENST00000449549.3
|
B3GNT9
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
| chr16_-_29934558 | 0.53 |
ENST00000568995.1
ENST00000566413.1 |
KCTD13
|
potassium channel tetramerization domain containing 13 |
| chr12_-_123634449 | 0.52 |
ENST00000542210.1
|
PITPNM2
|
phosphatidylinositol transfer protein, membrane-associated 2 |
| chr7_-_752577 | 0.52 |
ENST00000544935.1
ENST00000430040.1 ENST00000456696.2 ENST00000406797.1 |
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
Network of associatons between targets according to the STRING database.
First level regulatory network of GLIS2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 5.8 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.9 | 2.7 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.8 | 2.4 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.5 | 5.5 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.5 | 1.5 | GO:2000646 | lipid transport involved in lipid storage(GO:0010877) positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 1.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.5 | 1.4 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.4 | 1.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.4 | 1.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.4 | 1.4 | GO:1903979 | regulation of phosphatidylcholine catabolic process(GO:0010899) negative regulation of microglial cell activation(GO:1903979) |
| 0.4 | 1.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.3 | 0.7 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 | 1.0 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.3 | 1.5 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of platelet-derived growth factor production(GO:0090362) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.3 | 2.1 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.3 | 4.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.3 | 0.8 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.3 | 0.8 | GO:1902955 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.3 | 0.8 | GO:2000870 | positive regulation of female gonad development(GO:2000196) regulation of progesterone secretion(GO:2000870) |
| 0.3 | 3.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) protein maturation by protein folding(GO:0022417) |
| 0.3 | 0.8 | GO:1904316 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.2 | 0.7 | GO:1904339 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) positive regulation of immature T cell proliferation in thymus(GO:0033092) right lung development(GO:0060458) primary prostatic bud elongation(GO:0060516) epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.2 | 2.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.2 | 0.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 | 0.6 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.2 | 1.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 0.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.2 | 1.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.2 | 0.7 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.2 | 0.9 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.2 | 0.9 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 0.2 | 0.5 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.2 | 0.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 0.7 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
| 0.2 | 1.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 | 1.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 | 1.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.2 | 0.6 | GO:0060032 | notochord regression(GO:0060032) |
| 0.1 | 1.5 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 | 1.9 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 1.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.1 | 0.6 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.1 | 1.0 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.1 | 1.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.9 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.3 | GO:0052255 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.1 | 0.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 | 1.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 0.7 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 | 1.7 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.1 | 2.6 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.1 | 1.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 2.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 3.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 2.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 1.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.8 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.3 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.1 | 3.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.2 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.2 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.1 | 0.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 | 0.2 | GO:0043602 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
| 0.1 | 0.7 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 1.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 | 1.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 1.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 5.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 1.4 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 1.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.8 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.6 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 | 0.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 0.9 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.0 | 0.3 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
| 0.0 | 2.4 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 1.5 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.0 | 0.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 5.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 2.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
| 0.0 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 2.6 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.0 | 2.8 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.0 | 0.5 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.0 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 0.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.0 | 0.1 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.0 | 0.5 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 0.1 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.0 | 0.3 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.0 | 1.0 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 | 0.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 | 0.4 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.0 | 0.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 0.2 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.0 | 0.2 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) myoblast fate commitment(GO:0048625) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.0 | 0.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.0 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.0 | 0.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.0 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 0.0 | 0.6 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.0 | 1.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.0 | 0.1 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.0 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 | 0.3 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 | 0.1 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.0 | 0.1 | GO:0071469 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
| 0.0 | 1.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
| 0.0 | 0.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 3.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.2 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.0 | 0.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.0 | 0.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.0 | 4.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.0 | 0.4 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.0 | 0.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
| 0.0 | 0.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 | 0.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.0 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 | 0.2 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 1.7 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.0 | 0.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 1.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.0 | 0.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.0 | 0.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 | 1.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.0 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.0 | 0.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.0 | 1.1 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.7 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 | 0.1 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 | 0.5 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 0.0 | 0.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.0 | 0.4 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 1.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.5 | 1.4 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 0.4 | 4.5 | GO:0097486 | alveolar lamellar body(GO:0097208) multivesicular body lumen(GO:0097486) |
| 0.3 | 1.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.2 | 6.1 | GO:0042627 | chylomicron(GO:0042627) |
| 0.2 | 1.8 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 0.9 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.2 | 1.0 | GO:0070701 | mucus layer(GO:0070701) |
| 0.2 | 0.5 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.2 | 0.9 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 5.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 0.6 | GO:1990742 | microvesicle(GO:1990742) |
| 0.1 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 2.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.2 | GO:0035101 | FACT complex(GO:0035101) |
| 0.1 | 0.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.9 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.7 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 1.1 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.1 | 1.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.1 | 1.5 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 2.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 1.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.0 | 0.5 | GO:0000801 | central element(GO:0000801) |
| 0.0 | 1.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.0 | 1.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.0 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.0 | 0.1 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.0 | 0.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.0 | 1.5 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.9 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 1.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 2.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 1.0 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.0 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 1.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 3.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 0.4 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.0 | 3.4 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 1.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 2.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 2.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.0 | 0.2 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.0 | 0.2 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.0 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.4 | GO:0045179 | apical cortex(GO:0045179) |
| 0.0 | 2.2 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.0 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.1 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.0 | 0.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.0 | 2.6 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 4.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 2.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 2.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.0 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 1.2 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.1 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.0 | 0.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.0 | 2.1 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 1.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.0 | 3.0 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 1.1 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 0.8 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 0.8 | GO:0043198 | dendritic shaft(GO:0043198) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 7.3 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.7 | 3.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.4 | 1.2 | GO:0097258 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.4 | 1.2 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
| 0.3 | 2.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.3 | 1.0 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.3 | 1.3 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.3 | 1.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.2 | 3.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.2 | 1.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.2 | 0.6 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.2 | 1.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.2 | 3.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.2 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.2 | 0.6 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
| 0.2 | 2.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.2 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.2 | 0.8 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.2 | 4.2 | GO:0016918 | retinal binding(GO:0016918) |
| 0.2 | 1.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
| 0.1 | 4.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.1 | 1.0 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.1 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.1 | 0.4 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.8 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.1 | 2.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.9 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 1.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 1.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 0.5 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.1 | 2.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 5.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.3 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.1 | 0.8 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.2 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.1 | 0.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.1 | 0.5 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 1.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 0.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 1.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 0.3 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 1.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 0.9 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 0.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.0 | 1.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.0 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.0 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.0 | 1.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 1.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.0 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 2.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.0 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 0.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 7.4 | GO:0003823 | antigen binding(GO:0003823) |
| 0.0 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.3 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.0 | 0.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.1 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
| 0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.0 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 1.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.0 | 1.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.0 | 0.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 1.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 0.2 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.0 | 2.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 1.5 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 2.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 0.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.0 | 0.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.0 | 0.1 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
| 0.0 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 3.8 | GO:0020037 | heme binding(GO:0020037) |
| 0.0 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.2 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.0 | 0.2 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.0 | 0.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 1.4 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 0.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.0 | 2.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 1.5 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.2 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.0 | 0.0 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.0 | 1.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 0.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.0 | 1.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 3.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 4.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 1.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.0 | 1.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 1.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.0 | 1.5 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.0 | 2.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 2.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.0 | 2.2 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 2.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 3.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.0 | 1.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 1.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 1.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.0 | 0.5 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 1.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 1.0 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 3.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 2.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 2.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 2.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.0 | 1.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.0 | 1.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.0 | 1.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.0 | 1.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 1.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 1.8 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.0 | 1.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.0 | 0.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.0 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.0 | 1.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 0.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.0 | 0.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.0 | 0.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.0 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.0 | 0.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 1.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.3 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.0 | 2.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 3.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 1.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 1.5 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.0 | 0.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.0 | 0.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.0 | 1.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.4 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
| 0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 1.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.0 | 0.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |